Details for New Drug Application (NDA): 011467
✉ Email this page to a colleague
NDA 011467 describes TRANCOPAL, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the TRANCOPAL profile page.
The generic ingredient in TRANCOPAL is chlormezanone. There is one drug master file entry for this compound. Additional details are available on the chlormezanone profile page.
The generic ingredient in TRANCOPAL is chlormezanone. There is one drug master file entry for this compound. Additional details are available on the chlormezanone profile page.
Summary for 011467
| Tradename: | TRANCOPAL |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | chlormezanone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011467
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
